OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

Swedish Orphan Biovitrum AB/  SE0000872095  /

Cboe Europe DXE
2024-04-24  11:24:50 AM Chg. +3.50 Volume Bid11:26:00 AM Ask11:27:05 AM Market Capitalization Dividend Y. P/E Ratio
271.60SEK +1.31% 28,105
Turnover: 4.1 mill.		 271.40Bid Size: 37 271.80Ask Size: 83 95.96 bill.SEK - 36.25
GlobeNewswire 04-04 ADC Therapeutics Announces Updates on LOTIS-7 Clinical Trial Evaluating ZYNLONTA® in Combination wit...
GlobeNewswire 04-03 ADC Therapeutics to Host a Virtual Research Investor Event on Tuesday, April 9, 2024
GlobeNewswire 04-01 Autolus Therapeutics Announces Changes to its Board of Directors
GlobeNewswire 03-28 Third Harmonic Bio Appoints Geoff McDonough, M.D., to its Board of Directors
GlobeNewswire 03-13 ADC Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business U...
GlobeNewswire 03-06 ADC Therapeutics to Participate in the Guggenheim 5th Annual Healthy Altitudes Summit
GlobeNewswire 03-06 ADC Therapeutics to Host Fourth Quarter and Year-End 2023 Financial Results Conference Call on March...
GlobeNewswire 03-05 ADC Therapeutics Announces Abstracts Accepted for Presentation at the American Association for Cance...
GlobeNewswire 01-04 ADC Therapeutics Regains Compliance with NYSE Continued Listing Standards
GlobeNewswire 01-04 ADC Therapeutics Provides Business Updates
GlobeNewswire 2023-12-12 ADC Therapeutics Announces Initial Results from Investigator-Initiated Phase 2 Clinical Trial Evalua...
GlobeNewswire 2023-11-07 ADC Therapeutics Receives NYSE Notice of Non-Compliance With Continued Listing Standards
GlobeNewswire 2023-11-07 ADC Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates
GlobeNewswire 2023-11-06 Health Canada Approves DOPTELET (avatrombopag) for Two Indications in Thrombocytopenia
GlobeNewswire 2023-11-06 ADC Therapeutics to Participate in the Jefferies London Healthcare Conference
GlobeNewswire 2023-11-02 Galapagos reports third quarter 2023 results and releases new encouraging data from CAR-T studies fo...
GlobeNewswire 2023-11-02 ADC Therapeutics Announces Abstracts Accepted for Presentation at the 65th ASH Annual Meeting
GlobeNewswire 2023-11-01 Sensei Biotherapeutics Appoints Stephanie Krebs, MS, MBA, as Chief Business Officer
GlobeNewswire 2023-10-31 Selecta Announces Transition of Manufacturing and Clinical Operations of ImmTOR for SEL-212 to Comme...
GlobeNewswire 2023-10-24 ADC Therapeutics to Host Third Quarter 2023 Financial Results Conference Call on November 7, 2023
GlobeNewswire 2023-09-05 ADC Therapeutics to Participate in September Investor Conferences
GlobeNewswire 2023-08-31 ADC Therapeutics Announces Updates on ZYNLONTA® LOTIS Clinical Trial Programs at the Eleventh Annual...
Newsfile Corp 2023-08-23 SEC Charges Former Attorney at U.S.-Based Global Law Firm with Insider Trading
GlobeNewswire 2023-08-17 Selecta Biosciences Reports Second Quarter 2023 Financial Results and Updates on Strategic Initiativ...
GlobeNewswire 2022-03-28 Apellis Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Op...